首页> 美国卫生研究院文献>Oncotarget >Characteristics and comparison between diabetes mellitus and non-diabetes mellitus among chronic kidney disease patients: A cross-sectional study of the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)
【2h】

Characteristics and comparison between diabetes mellitus and non-diabetes mellitus among chronic kidney disease patients: A cross-sectional study of the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)

机译:慢性肾脏病患者的糖尿病特征与非糖尿病特征的比较:中国慢性肾脏病队列研究的横断面研究(C-STRIDE)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although the prevalence of chronic kidney disease (CKD) and diabetes mellitus (DM) is increasing globally, information on Chinese CKD patients with DM is lacking. A total of 3499 pre-dialysis CKD patients from across China were enrolled in the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE) between November 2011 and April 2016. We divided the C-STRIDE patients into CKD with DM and CKD without DM groups and compared their clinical, demographic, and laboratory data in this cross-sectional study. CKD patients with DM were older, had a higher male-to-female ratio, and had more complications than CKD patients without DM. Age, smoking, and 24-h urinary protein levels were associated with co-occurrence of CKD and DM. Less than 50% of patients in either group took antilipemic, cardiovascular, cerebrovascular, or anti-anemic drugs. In addition, only 18.38% of CKD patients with DM had undergone a renal biopsy, and diabetic nephropathy was confirmed in 35.4% of them. Our findings suggest that several types of medication and renal biopsies should be used more frequently in the treatment of Chinese CKD patients with DM.
机译:尽管全球范围内慢性肾脏病(CKD)和糖尿病(DM)的患病率正在上升,但缺乏有关中国CKD DM患者的信息。在2011年11月至2016年4月之间,共有3499名来自中国各地的透析前CKD患者参加了中国慢性肾脏病队列研究(C-STRIDE)。我们将C-STRIDE患者分为具有DM的CKD和没有DM的CKD。分组并在此横断面研究中比较了他们的临床,人口统计学和实验室数据。与没有DM的CKD患者相比,患有DM的CKD患者年龄更大,男女比例更高,并且并发症更多。年龄,吸烟和24小时尿蛋白水平与CKD和DM的同时出现有关。两组中不到50%的患者服用了抗血脂药,心血管药,脑血管药或抗贫血药。此外,只有CKD的DM患者中有18.38%接受了肾脏活检,其中35.4%的患者确认为糖尿病性肾病。我们的发现表明,在中国CKD DM患者中,应更频繁地使用几种药物和肾脏活检标本。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号